Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Neuren Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: Even bacteria fighter Next Science is feeling the coronavirus pinch
Health & Biotech
Health: Neuren’s mice are happily burying marbles after PMS neurotherapy
Health & Biotech
Health: Neuren gets extra FDA push for its treatment for rare Rett disease
Health & Biotech
Christmas may have come early for Biotron and its HIV cure
Health & Biotech
Biotech exec pay — are they delivering returns that equal their pay packets?
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
Health & Biotech
The life sciences investment wave is building. Here’s how to ride it.
Health & Biotech
Health: Roots’ cannabis-cooling tech might help boost crop yields by up to 118%
Health & Biotech
Health: Respiri will begin a 4,500-bed trial of its ‘wheezo’ asthma device in India next month
Health & Biotech
